ResMed

ResMed

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$1,414,814
$1,463,647
$1,431,406
$1,422,808
Gross Profit
870,567
861,219
890,979
884,660
EBITDA
585,710
503,833
583,631
566,426
EBIT
543,969
448,712
514,599
504,096
Net Income
418,413
383,432
398,732
392,593
Net Change In Cash
1,414,814
1,463,647
1,431,406
1,422,808
Free Cash Flow
373,682
1,649,544
520,478
305,190
Cash
1,010,742
1,469,234
1,660,513
1,417,069
Basic Shares
143,411
144,976
147,037
147,037

Annual Financials

Values in thousands2026-06-302025-06-302024-06-302023-06-30
Revenue
$5,653,443
$5,146,327
$4,685,297
$4,222,993
Gross Profit
3,451,739
3,054,970
2,655,303
2,355,662
EBITDA
2,152,612
1,913,377
1,533,543
1,359,841
EBIT
1,908,460
1,677,566
1,317,334
1,162,279
Net Income
1,523,293
1,400,723
1,020,951
897,556
Net Change In Cash
5,653,443
5,146,327
4,685,297
4,222,993
Free Cash Flow
1,649,544
1,661,723
1,286,404
559,299
Cash
1,469,234
1,209,450
238,361
227,891
Basic Shares
146,054
147,340
147,550
147,455

Earnings Calls

QuarterEPS
2026-09-30
$2.91
2026-06-30
$2.95
2026-03-31
$2.86
2025-12-31
$2.81